Register and Pay by Friday, DECEMBER 6 & Save Up to $400!
February 18-19, Boston MA
Accelerate collaboration and partnering across neurology and psychiatry pipelines and technologies, to reduce risk, validate technologies, and deliver better biodistribution of safe and efficacious molecules to the CNS
CONFIRMED TO ATTEND
Why Neuroscience Innovation Pharma partnering Summit?
"The opportunity had gone cold since the initial chats, with the other party generally hard to get hold of. Being able to use the partnering app ahead of the conference to not only find a time but have a table reserved for us to hash out a deal was super valuable and enabled us to close the partnership." Attendee ADC & Radiopharmaceuticals Pharma Partnering Summit
More Targeted
Connect with a targeted critical mass of decision-makers aligned with your strategic and scientific goals. Increase hit rate and efficiency of networking with an entire conference of viable partners. From large molecule delivery platforms to complementary research targets, to CNS drug delivery technologies
Earlier Opportunity
Build stronger relationships with key pharma and investor contacts to emphasize your company's competitive edge. Engage face-to-face and have time to schedule follow-up chats without the intensity of a larger crowd.
*The average number of meetings that result in follow-up after the conference is 4.
With Scientific Insights
From the safety and immunogenicity of oligonucleotides to biodistribution to target tissues in the brain and efficacious targets of neuroinflammation. Position your company at the front of scientific innovation to show where you add value, as pharma and investors gain strategic insights.
*Statistics from ADC and Radiopharmaceuticals iteration, September 2024
Key Figures from Partnering Series
meetings through the partnering portal
acceptance rate of meetings, versus 11% industry standard
total attendees, including: 20+ pharma, 65+ biotech
companies
director level and above
Size of Networking Opportunity
Total Audience Networking
Creating Alignment Through Targeted Critical Mass:
Exclusive to the neuroscience pharma, biotech, and investor community, you are guaranteed a greater number of strategically matched interactions when networking candidly. Free from CROs/CDMOs or other service providers, maximize speaking with the highest priority contacts for your company while they and you are free from conflicting priorities.
Interested Group Matchmaking & Speed Dating
Group Matchmaking & “Speed Dating” Style Networking
Tell us which pharma you want to meet in advance, and we will coordinate face-to-face, sit-down meetings with them during protected networking time at the pharma matchmaking tables on day one.
With speed networking then running on the morning of day two, be certain you have met every other attendee and have the opportunity to reconnect before the conference finishes.
Individual Meetings: One-on-One Partnering™
The industry’s favorite partnering portal, search the full attendee list, message and pre-schedule meetings in calendars ahead of the conference, and automatically book private meeting spaces: the most efficient way to set yourself up for success.
EXPERT SPEAKERS INCLUDE
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy
AbbVie
Jenny Laird
Vice President, Search & Evaluation Neuroscience
Eli Lilly
Vidya Nadar
Director, Search & Evaluation, Rare & Neurological Disorders
Sanofi
David Donabedian
Executive Partner
Longwood Fund
Stacie Weninger
President
F-Prime Capital
OTHER HANSON WADE SUMMITS
